2019 Health for Humanity Report
A young boy smiling in front of blue building
A young boy smiling in front of blue building

Mlolongo Blue Box Clinic, Kenya.

Better Health for All
Better Health for All Innovating for Better Health

R&D: Medical Devices

In a radically changing environment, we make connections across science and technology to combine our own expertise in surgery, orthopaedics, interventional solutions and vision care with the big ideas of others to design and deliver innovative solutions for doctors and patients. Areas of progress in 2019 include:

Advancing digital surgery: Part of our strategy to create the next frontier of surgery is empowering healthcare providers and surgeons to drive even better outcomes for patients. We announced our acquisition of Auris Health, a privately held developer of robotic platform technology, currently focused on enabling new possibilities in lung cancer procedures. This acquisition accelerates our entry into robotics with a FDA-cleared platform currently available in the United States.

In this new era of healthcare, we’re aiming to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer. We believe the combination of best-in-class robotics, advanced instrumentation and unparalleled end-to-end connectivity will make a meaningful difference in patient outcomes.
Ashley McEvoy Executive Vice President, Worldwide Chairman, Medical Devices Johnson & Johnson

Improving surgical outcomes: Johnson & Johnson Medical Devices introduced our new ECHELON CIRCULAR Powered Stapler to help address complications associated with colorectal, gastric and thoracic surgery. When using staples or sutures, there is a risk of complications from leaks at the staple line, which can lead to increased discomfort for the patient, longer hospital stays and potentially serious illness. This new stapler provides gentler handling to reduce the force required to complete the stapling process and is proven to reduce leaks by up 61% compared to similar devices. Read more here.

New knee replacement technology: We introduced the ATTUNE Cementless Knee as an addition to our knee solutions range. The cementless knee replacement is particularly relevant for younger, more energetic patients who have healthy, strong bone and wish to maintain an active lifestyle. This cementless option, which is based on biological fixation and in-growth of the implant to bone, promises to enable this. The ATTUNE Cementless Knee features several patented technologies designed to improve knee function. Read more here.

New registry for patients with liver disorders: Johnson & Johnson Medical Devices launched a new global registry to collect and analyze real-world data on patients with soft tissue liver lesions. The observational registry will follow approximately 1,500 patients worldwide for a total of five years from the date of their first liver ablation procedure with Ethicon's NEUWAVE Microwave Ablation System, our minimally invasive microwave ablation technology. The registry will be an important contribution to our understanding of this liver ablation procedure and provide robust clinical evidence to inform treatment decisions and improvements in procedural efficiency and patient outcomes.

Helping people see better, connect better, live better: Johnson & Johnson Vision, part of our Medical Devices business, launched 10 new products in 2019. Included in these was the TECNIS Eyhance Intraocular Lens (IOL), the first monofocal IOL to deliver improved intermediate vision and 20/20 distance vision. In addition, the Company showed positive Phase 3 clinical results on its first-of-its-kind drug-eluting antiallergy contact lens. Johnson & Johnson Vision also launched its inaugural “Vision for Good” community impact report detailing efforts to provide access to eye care for those in need through advocacy and education, and serving more than 40 million people to date.

Back To R&D: Pharmaceutical Up Next R&D: Consumer Health
You are leaving jnj.com and entering a third-party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties.